Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle

References

Page 1

	Year	Citations
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults Eugenia E. Calle, Carmen Rodríguez, Kimberly A Walker-Thurmond, New England Journal of Medicine	2003	7.7K
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study Gillian Reeves, Kirstin Pirie, Valerie Beral, BMJ	2007	1.5K
Effect of Obesity on Prognosis After Early-Stage Breast Cancer Marianne Ewertz, Maj‐Britt Jensen, K. Gunnarsdóttir, Journal of Clinical Oncology	2010	589
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Libby M. Morimoto, Emily White, Z. Chen, Cancer Causes & Control	2002	566
Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer Sherene Loi, Roger L. Milne, Michael Friedländer, Cancer Epidemiology Biomarkers & Prevention	2005	326
Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial Ivana Šestak, W. Distler, John Forbes, Journal of Clinical Oncology	2010	308
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience Gilles Berclaz, S. Li, Karen N. Price, Annals of Oncology ObesitySurgical OncologyBody CompositionBreast OncologyMedicine	2004	259
Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women Jennifer M. Petrelli, Eugenia E. Calle, Carmen Rodríguez, Cancer Causes & Control	2002	232
Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer James J. Dignam JNCI Journal of the National Cancer Institute	2003	224
Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial Georg Pfeiler, Robert Königsberg, Christian Fesl, Journal of Clinical Oncology	2011	220

Page 1